Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINHALATIONGeneric

TORNALATE

BITOLTEROL MESYLATE

Standard Dose
0.2%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview TORNALATE is listed in Drugs@FDA under application 019548 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient BITOLTEROL MESYLATE Form and strength SOLUTION;INHALATION - 0.2% Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview TORNALATE is listed in Drugs@FDA under application 019548 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient BITOLTEROL MESYLATE Form and strength SOLUTION;INHALATION - 0.2% Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.